Gene · 4093
Papers2,192
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,192
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH. | Eur Respir J | 2023 | 36302552 | PubTator, text mining | PubMed |
| A rare homozygous missense GDF2 (BMP9) mutation causing PAH in siblings: Does BMP10 status contribute? | Am J Med Genet A | 2023 | 36259599 | PubTator, text mining | PubMed |
| AUTS2 Controls Neuronal Lineage Choice Through a Novel PRC1-Independent Complex and BMP Inhibition. | Stem Cell Rev Rep | 2023 | 36258139 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Bone morphogenetic protein pathway responses and alterations of osteogenesis in metastatic prostate cancers. | Cancer Rep (Hoboken) | 2023 | 36054271 | PubTator, text mining | PubMed |
| In Vitro Effects of Acitretin on Human Neuronal SH-SY5Y Cells. | Neurochem Res | 2023 | 35987975 | PubTator, text mining | PubMed |
| Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-β1/Smad2/3 Pathway. | Curr Cancer Drug Targets | 2023 | 35975844 | PubTator, text mining | PubMed |
| Recent Advances and Future Prospects of Treatment of Pulmonary Hypertension. | Curr Probl Cardiol | 2023 | 35500734 | PubTator, text mining | PubMed |
| ACVR1-activating mutation causes neuropathic pain and sensory neuron hyperexcitability in humans. | Pain | 2023 | 35442931 | PubTator, text mining | PubMed |
| Deciphering endothelial heterogeneity in health and disease at single-cell resolution: progress and perspectives. | Cardiovasc Res | 2023 | 35179567 | PubTator, text mining | PubMed |
| Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice. | Rev Cardiovasc Med | 2022 | 36875282 | PubTator, text mining | PubMed |
| Diagnosis and management of pulmonary arterial hypertension. | Breathe (Sheff) | 2022 | 36865939 | PubTator, text mining | PubMed |
| Transcription factors in the pathogenesis of pulmonary arterial hypertension-Current knowledge and therapeutic potential. | Front Cardiovasc Med | 2022 | 36684555 | PubTator, text mining | PubMed |
| Modification of m5C regulators in sarcoma can guide different immune infiltrations as well as immunotherapy. | Front Surg | 2022 | 36684288 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived extracellular vesicles: a possible therapeutic strategy for orthopaedic diseases: a narrative review. | Biomater Transl | 2022 | 36654775 | PubTator, text mining | PubMed |
| Immune Complex Glomerulonephritis in a Patient with Myelodysplastic Syndrome with Ring Sideroblasts Treated with Luspatercept. | Diagnostics (Basel) | 2022 | 36611303 | PubTator, text mining | PubMed |
| Kartogenin Improves Osteogenesis of Bone Marrow Mesenchymal Stem Cells via Autophagy. | Stem Cells Int | 2022 | 36591373 | PubTator, text mining | PubMed |
| Transcriptomic analysis of human ALS skeletal muscle reveals a disease-specific pattern of dysregulated circRNAs. | Aging (Albany NY) | 2022 | 36585921 | PubTator, text mining | PubMed |
| Dysregulation of the immune response in TGF-β signalopathies. | Front Immunol | 2022 | 36569843 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4093/papers?page=11